Stimulants

Synonyms
Cocaine
crack
methamphetamine
amphetamine
ADHD
uppers
speed
meth

Racial/Ethnic and Geographic Trends in Combined Stimulant/Opioid Overdoses, 2007–2019

In the United States, combined stimulant/opioid overdose mortality has risen dramatically over the last decade. These increases may particularly affect non-Hispanic Black and Hispanic populations. We used death certificate data from the US National Center for Health Statistics (2007–2019) to compare state-level trends in overdose mortality due to opioids in combination with 1) cocaine and 2) methamphetamine and other stimulants (MOS) across racial/ethnic groups (non-Hispanic White, non-Hispanic Black, Hispanic, and non-Hispanic Asian American/Pacific Islander).
Posted Date
02/16/22

RCORP Grantee Data Collection Resources (Psychostimulant Cohort)

HRSA and JBS have developed guidance to assist your RCORP data collection and Performance Improvement Measurement System (PIMS) reporting efforts. These measures are pending OMB clearance and are subject to revision. This page contains the RCORP data collection resources for the Psychostimulant Support grantees only. These documents will be updated as new guidance or data sources are identified. We encourage you to bookmark this page so you have the latest version available. Please send any measure-related questions to your HRSA Project Officer or email: rcorp-eval@jbsinternational.com.
Posted Date
02/09/22

RCORP-Psychostimulant Support (RCORP-PS) Guidance Modules (B)

We are pleased to announce RCORP-Psychostimulant Support (RCORP-PS) guidance modules are now available. Module B – Program Implementation Guidance for Treatment and Recovery Core Activities shares information regarding the three required treatment and recovery core activities grantees will put into practice. You can access them below.

Posted Date
11/01/21

RCORP-Psychostimulant Support (RCORP-PS) Guidance Modules (A)

We are pleased to announce RCORP-Psychostimulant Support (RCORP-PS) guidance modules are now available. Module A – Program Implementation Guidance for Prevention Core Activities provides grantees with information about how to implement the three required prevention core activities. You can access them below.

Posted Date
11/01/21

RCORP 2021 (Region 5 Meeting): Stimulants 2021, An Update—Clinical Issues and Treatments

Stimulant intoxication, withdrawal, and psychosis have accepted and established treatment strategies. Several lifesaving harm reduction interventions/services are available. There are no Food and Drug Administration-approved medications for treatment of stimulant use disorder, although several are promising. Behavioral treatment, especially the use of contingency management (and other approaches with supportive evidence), has by far the best evidence of effectiveness. The presenter reviewed topics of importance to clinicians treating individuals with stimulant use disorder. Rick Rawson, PhD, University of Vermont Rural Center of Excellence
Posted Date
10/14/21

RCORP 2021 (Region 5 Meeting): Effective Harm Reduction Strategies for People Who Actively Use Opioids and/or Psychostimulants

Participants learned evidenced-based harm reduction strategies to keep people who use opioids and psychostimulants alive with reduced disease burden. Presenters discussed methods of engaging people who actively use opioids and/or psychostimulants, harm reduction interventions, overdose prevention and response, overamping prevention and response, and linkages to care. Robert Childs, MPH, JBS International Christine Rodriguez, MPH, Vital Strategies
Posted Date
10/14/21

Overamping

Have you ever felt too uncomfortable or weird (not in a nice way) after taking stims? You could have been  “overamping.” Stimulants like crack/cocaine and meth can lead to side effects that are unwanted and uncomfortable or potentially dangerous. Knowing what it is and what to do can help you be prepared if it happens. Overamping happens when the effects of a stimulant become overwhelming, distressing, and/or dangerous.Overamping is specific to “overdosing” on stims like crack, cocaine, or meth. Using the word “overamping” helps to differentiate from an opioid overdose since they are different in how it happens, how it appears, and how to respond.
Posted Date
08/19/21

Eastern Regional Meeting (Regions 1, 2 & 3): Effective Harm Reduction Strategies for People Who Actively Use Opioids and/or Psychostimulants

Effective Harm Reduction Strategies for People Who Actively Use Opioids and/or Psychostimulants
Participants will learn evidenced-based harm reduction strategies to keep people who use opioids and psychostimulants alive with reduced disease burden. Presenters will discuss methods of engaging people who actively use opioids and/or psychostimulants, harm reduction interventions, overdose prevention and response, overamping prevention and response, and linkages to care.

Robert Childs, MPH, JBS International 
Christine Rodriguez, MPH, Vital Strategies

Posted Date
08/04/21

Using ODMAP Data to Target Prevention Activities

This program brief highlights the Alliance for Prevention and Wellness (APW) use of Overdose Detection Mapping Application Program (ODMAP) data to target a broad range of substance use prevention and education activities to ZIP codes with the highest rate of overdoses. Source: Bureau of Justice Assistance (BJA)-Supported Comprehensive Opioid, Stimulant, and Substance Abuse Program (COSSAP).
Posted Date
08/04/21